Literature DB >> 9050118

Patient attributes and expressed emotion as risk factors for psychotic relapse.

D H Linszen1, P M Dingemans, M A Nugter, A J Van der Does, W F Scholte, M A Lenior.   

Abstract

In the context of a prospective, controlled treatment study, contrasting family interventions with individual treatment, the role of expressed emotion (EE) as a predictor of relapse was examined in patients with recent-onset schizophrenia and related disorders (n = 97). EE was compared with 13 predictor variables. The variables, taken from EE and family intervention studies, related to demography, premorbid functioning, present and past illness history, and comorbid substance abuse. Psychotic relapse was operationalized with a conservatively measured relapse criterion, composed of monthly ratings based on the Brief Psychiatric Rating Scale and on clinical judgment during the 12 months of outpatient treatment. Of the 14 predictor variables entered in stepwise survival analyses, 6 variables had probable predictive power on the conservative relapse criterion. These variables were entered in a Cox regression model. EE turned out to be the major predictor of relapse in the overall sample (hazard ratio [HR] 4.90; confidence interval [CI] 1.05-22.92). This finding remained when only patients with a first psychotic episode (p = 0.02) and patients in the individual treatment condition (p = 0.001) were examined. Cannabis abuse was the major predictor of relapse in patients with high-EE families (HR 4.27; CI 1.12-16.29).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050118     DOI: 10.1093/schbul/23.1.119

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

Review 1.  Supportive therapy for schizophrenia.

Authors:  Lucy A Buckley; Nicola Maayan; Karla Soares-Weiser; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2015-04-14

2.  Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Authors:  A M Auther; D McLaughlin; R E Carrión; P Nagachandran; C U Correll; B A Cornblatt
Journal:  Psychol Med       Date:  2012-04-30       Impact factor: 7.723

3.  Risk and Protective Factors, Perceptions of Family Environment, Ethnicity, and Schizophrenia Symptoms.

Authors:  Kayla Gurak; Amy Weisman de Mamani
Journal:  J Nerv Ment Dis       Date:  2016-08       Impact factor: 2.254

Review 4.  Marijuana Use in the Era of Changing Cannabis Laws: What Are the Risks? Who is Most at Risk?

Authors:  William V Stoecker; Emily E Rapp; Joseph M Malters
Journal:  Mo Med       Date:  2018 Sep-Oct

Review 5.  Schizophrenia: a systemic disorder.

Authors:  Brian Kirkpatrick; Brian Miller; Clemente García-Rizo; Emilio Fernandez-Egea
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-07

6.  Effect of caregivers' expressed emotion on the care burden and rehospitalization rate of schizophrenia.

Authors:  Xia Wang; Qiongni Chen; Min Yang
Journal:  Patient Prefer Adherence       Date:  2017-09-06       Impact factor: 2.711

7.  Psychological Interventions for Young People With Psychotic Disorders: A Systematic Review.

Authors:  Vera Gergov; Branka Milic; Henriette Löffler-Stastka; Randi Ulberg; Eleni Vousoura; Stig Poulsen
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 5.435

8.  Measuring individual benefits of psychiatric treatment using longitudinal binary outcomes: Application to antipsychotic benefits in non-cannabis and cannabis users.

Authors:  Xuan Zhang; Jose de Leon; Benedicto Crespo-Facorro; Francisco J Diaz
Journal:  J Biopharm Stat       Date:  2020-06-08       Impact factor: 1.503

9.  Gene-Environment Interaction in a Conditional NMDAR-Knockout Model of Schizophrenia.

Authors:  Alexei M Bygrave; Simonas Masiulis; Dimitri M Kullmann; David M Bannerman; Dennis Kätzel
Journal:  Front Behav Neurosci       Date:  2019-01-10       Impact factor: 3.558

Review 10.  Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?

Authors:  Alexei M Bygrave; Kasyoka Kilonzo; Dimitri M Kullmann; David M Bannerman; Dennis Kätzel
Journal:  Front Psychiatry       Date:  2019-11-21       Impact factor: 4.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.